PG Procter & Gamble Company
XNYS
161.24
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $137.62 – $167.25
- YTD
- +13.71%
- IV Rank (30D)
- 12.37
- Straddle Price
- $6.86
- P/C Vol Ratio
- 0.23
- Market Cap
- $373.2B
- Open
- $164.00
- Day Range
- $160.64 – $164.50
- Volume
- 10,331,610
- Prev Close
- $165.59
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 5.12% |
| Beta vs SPY | 0.60 |
| Cost of Equity (CAPM) | 8.11% (VRP-adj) |
| WACC | 8.00% |
| Volatility Risk Premium | +21.4pp (IV − HV30) |
| Effective Tax Rate | 20.8% |
| Rev. Growth (YoY, DCF input) | -5.3% |
| DCF Horizon | 12 years explicit + fade |
| Free Cash Flow (TTM) | $15.1B |
| Return on Equity (TTM) | 29.1% |
| Book / Price | 13.5% |
| Gross Margin (TTM) | 50.2% |
| FCF Margin (TTM) | 17.4% |
| Debt / Equity | 0.42 |
| Quality Score | 5/6 — high quality (12y DCF) |
| Market-Implied Growth | +8.3% (reverse-DCF on current price) |
| SMA 50 | $148.03 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $152.02 |
| Bollinger Width / SMA20 | 10.1% (drives anchor stability) |
| Net Debt | $12.9B |
| Market Cap | $402B |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $64.12 | 16% | |
| DDM (Gordon) | $38.06 | 13% | |
| Peer P/E | $185.99 | 7% | median 28.1× · 8 peers |
| Peer EV/EBITDA | $166.76 | 7% | median 18.2× · 8 peers |
| Peer P/B | $230.01 | 1% | median 10.3× · 6 peers |
| Peer P/S | $99.78 | 5% | median 2.8× · 8 peers |
| Market Anchor (SMA50) | $148.03 | 33% | stability 99% (BB-width) |
| Options Expected (B-L 30d) | $167.23 | 16% | 38 strikes · skew +0.92 |

- Industry (SIC)
- SOAP, DETERGENTS, CLEANG PREPARATIONS, PERFUMES, COSMETICS (2840) · industry map
- Exchange
- XNYS
- Market Cap
- $373.2B
- Employees
- 104,000
- List Date
- 1950-03-22
- CIK
- 0000080424
- Headquarters
- Cincinnati, OH
- Homepage
- https://us.pg.com
Since its founding in 1837, Procter & Gamble has become one of the world's largest consumer product manufacturers, with annual sales of more than $87 billion. It operates with a lineup of leading brands, including more than 20 that generate annual global sales of more than $1 billion each, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside the US represent just over half of the firm's consolidated total.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | -6.97% | -1.50% | -6.06% | 5.65% | 0.01% | 7.04% | -0.30% |
| Feb | -4.22% | -2.41% | -3.93% | -0.15% | 3.01% | 9.15% | 0.24% |
| Mar | 8.96% | -0.33% | 8.01% | 2.14% | -2.94% | -11.66% | 0.70% |
| Apr | -0.64% | 3.52% | 4.60% | 1.63% | -4.68% | 2.08% | 1.08% |
| May | -0.11% | -6.63% | -8.99% | 0.70% | 6.19% | -2.51% | -1.89% |
| Jun | 1.54% | -1.27% | 5.40% | 0.16% | -5.04% | 4.53% | 0.89% |
| Jul | 5.17% | -4.93% | 2.49% | -1.20% | -6.67% | -1.61% | -1.12% |
| Aug | 0.36% | -3.47% | -1.22% | 3.53% | 4.24% | 0.10% | 0.59% |
| Sep | -2.81% | -9.59% | -5.60% | -0.76% | -2.75% | -0.64% | -3.69% |
| Oct | 2.44% | 4.79% | 3.33% | -4.54% | -1.83% | 11.86%* | 2.68% |
| Nov | 1.36% | 10.59% | 2.61% | 8.58% | 0.09% | -- | 4.65% |
| Dec | 11.73% | 1.55% | -4.01% | -6.71% | -2.80% | -- | -0.05% |
| Total | 16.44% | -10.73% | -4.87% | 8.41% | -13.15% | 17.53% | 2.27% |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
Here is the stock analysis report for PG:
Executive Summary
Overall Assessment: NEUTRAL (Confidence Level: 7/10)
Key Drivers: Technical indicators suggest a range-bound market with some bearish momentum signals, while news sentiment leans positive.
Primary Risks: High volatility, potential breakouts, and diverging technical and news signals.
Investment Thesis: PG's recent price action is characterized by a consolidation phase, with bearish momentum signals and a neutral RSI. News sentiment is generally positive, but some negative headlines have tempered expectations.
Recent News Sentiment Impact: The overall sentiment remains neutral, with no significant catalysts driving the stock's movements.
Technical Analysis
Trend Direction:
- Short-term (1-4 weeks): Consolidation
- Medium-term (1-3 months): Range-bound
- Long-term (3-12 months): Uptrend
Support/Resistance Levels:
- SMA 20: $144.74
- SMA 50: $146.45
- SMA 200: $147.51
- Upper Bollinger Band: $147.64
Momentum Signals:
- RSI: 42.39 (neutral)
- MACD: -0.41 / Signal: -0.08 / Histogram: -0.33 (bearish)
- Stochastic %K: 26.81
- Stochastic %D: 46.03
- Williams %R: -82.92
Volume Analysis:
- Volume SMA 20: 9186886.75
- On-Balance Volume (OBV): 70900955.36
- Volume Rate of Change: 32.03%
News & Sentiment Analysis
Recent Headlines Summary:
- Neutral news headlines dominate, with some positive sentiment and no significant negative catalysts.
Sentiment Assessment: NEUTRAL
Catalyst Identification: No imminent earnings or product launch events.
Market Narrative: The market narrative is neutral, reflecting the consolidation phase and mixed technical signals.
Risk & Volatility Assessment
Risk Interpretation:
- Beta: -0.06 (vs SPY)
- Alpha: -0.07
- Correlation: -0.04
Volatility Regime:
- Current vs historical volatility levels: High volatility
Options Market Signals:
- IV Rank: 0.7% (Low)
- Current IV: 28.7%
- Expected Move: $6.23 (29 DTE), 7-DTE: $3.09
- Volume Flow: 148 calls vs 531 puts
- Open Interest: 4,193 calls vs 1,233 puts
- Put/Call Volume Ratio: 3.59 (Bearish sentiment)
- Put/Call OI Ratio: 0.29
Downside Protection:
- Support levels: SMA 20 and SMA 50
- Risk management considerations: Monitor for breakouts or diverging signals.
Market Context & Positioning
Sector Performance:
- Relative strength vs sector/market: Neutral
Institutional Activity:
- Volume patterns suggesting institutional interest: None notable
Correlation Analysis:
- How stock moves relative to market (R-squared interpretation): -0.04
Relative Valuation:
- Position within trading range: Consolidation
Key Levels & Action Items
Critical Price Levels:
- SMA 20: $144.74
- SMA 50: $146.45
- Upper Bollinger Band: $147.64
Breakout/Breakdown Levels:
- Technical levels that could trigger significant moves: None notable
Time-Sensitive Catalysts:
- No imminent earnings or product launch events.
Risk Management:
- Stop-loss levels and position sizing considerations: Monitor for breakouts or diverging signals.
Please note that this report is based on the provided data, and actual market conditions may differ.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-01-20 | Pre-Market | 3.03% | 1.25% | 0.41x | Within |
| 2021-04-20 | Pre-Market | 2.47% | 0.83% | 0.34x | Within |
| 2021-07-30 | Pre-Market | 1.78% | 1.97% | 1.11x | Exceeded |
| 2021-10-19 | Pre-Market | 2.33% | 1.18% | 0.51x | Within |
| 2022-01-19 | Pre-Market | 3.23% | 3.36% | 1.04x | Exceeded |
| 2022-04-20 | Pre-Market | 3.11% | 2.66% | 0.86x | Within |
| 2022-07-29 | Pre-Market | 2.60% | 6.18% | 2.38x | Exceeded |
| 2022-10-19 | Pre-Market | 3.99% | 0.93% | 0.23x | Within |
| 2023-01-19 | Pre-Market | 3.40% | 2.73% | 0.80x | Within |
| 2023-04-21 | Pre-Market | 2.08% | 3.46% | 1.66x | Exceeded |
| 2023-07-28 | Pre-Market | 2.78% | 2.83% | 1.02x | Exceeded |
| 2023-10-18 | Pre-Market | 3.13% | 2.58% | 0.82x | Within |
| 2024-01-23 | Pre-Market | 2.91% | 4.14% | 1.42x | Exceeded |
| 2024-04-19 | Pre-Market | 2.72% | 0.54% | 0.20x | Within |
| 2024-07-30 | Pre-Market | 3.02% | 4.84% | 1.60x | Exceeded |
| 2024-10-18 | Pre-Market | 2.81% | 0.58% | 0.21x | Within |
| 2025-01-22 | Pre-Market | 3.45% | 1.87% | 0.54x | Within |
| 2025-04-24 | Pre-Market | 3.83% | 3.74% | 0.98x | Within |
| 2025-07-29 | Pre-Market | 3.59% | 0.32% | 0.09x | Within |
| 2025-10-24 | Pre-Market | 3.04% | 0.18% | 0.06x | Within |
| 2026-01-22 | Pre-Market | 3.32% | 2.65% | 0.80x | Within |
| 2026-04-24 | Pre-Market | 3.27% | 1.70% | 0.52x | Within |
| 2026-07-29 | Pre-Market | 3.17% | 1.87% | 0.59x | Within |
| 2026-10-22 | Pre-Market | 3.04% | 5.58% | 1.84x | Exceeded |
Earnings calendar: this week’s reports with expected vs actual moves →
PG Options Activity & IV Rank
PG IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Options Flow
ATM Options Pricing
Chain Summary
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Estimated net dealer gamma is at the 93rd percentile of this name's own daily history, near the high end of its range. This describes current positioning; it is not a forecast or a trading signal.
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
Risk Metrics
Analysis Details
Data Points: 251
Period: 252 trading days
Negative beta - stock moves opposite to market
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Point72 Hedge fund Steve Cohen | $633.9M | #10 of 1945 | +105.8% | 13F | |
| Fundsmith Asset manager Terry Smith | $598.1M | #9 of 41 | -2.9% | 13F | |
| Citadel Hedge fund Ken Griffin | $426.1M | #58 of 6285 | +323.9% | 13F | |
| Millennium Management Hedge fund Izzy Englander | $217.4M | #126 of 3716 | +43.3% | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $187.8M | #72 of 4729 | +7.1% | 13F | |
| Bridgewater Associates Hedge fund Ray Dalio | $20.2M | #204 of 997 | -12.8% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
PG Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Jane Street Group, LLC Custodian | $629.17M | 21.09% | 2026-06-30 |
| 2 | Susquehanna International Group, LLP Custodian | $552.10M | 18.50% | 2026-06-30 |
| 3 | Point72 Asset Management, L.P. | $300.60M | 10.07% | 2026-06-30 |
| 4 | Citadel Advisors LLC Custodian | $298.71M | 10.01% | 2026-06-30 |
| 5 | IMC-Chicago, LLC Custodian | $153.31M | 5.14% | 2026-06-30 |
| 6 | NOMURA HOLDINGS INC | $112.68M | 3.78% | 2026-06-30 |
| 7 | Gladius Capital Management LP | $105.76M | 3.54% | 2026-06-30 |
| 8 | Simplex Trading, LLC Custodian | $77.50M | 2.60% | 2026-06-30 |
| 9 | TORONTO DOMINION BANK | $70.39M | 2.36% | 2026-06-30 |
| 10 | Walleye Trading LLC | $57.60M | 1.93% | 2026-06-30 |
| 11 | Wolverine Trading, LLC Custodian | $57.10M | 1.91% | 2025-09-30 |
| 12 | GROUP ONE TRADING LLC Custodian | $50.75M | 1.70% | 2026-06-30 |
| 13 | UBS Group AG Custodian | $42.87M | 1.44% | 2026-06-30 |
| 14 | Hudson Bay Capital Management LP | $39.97M | 1.34% | 2026-06-30 |
| 15 | Millennium Management LLC Custodian | $32.08M | 1.08% | 2026-06-30 |
| 16 | Allianz Asset Management GmbH | $30.78M | 1.03% | 2026-06-30 |
| 17 | Eisler Capital Management Ltd. | $29.86M | 1.00% | 2025-09-30 |
| 18 | Goldman Sachs Group Inc Custodian | $28.81M | 0.97% | 2026-06-30 |
| 19 | Balyasny Asset Management L.P. | $27.92M | 0.94% | 2026-06-30 |
| 20 | BNP Paribas Financial Markets Custodian | $27.00M | 0.90% | 2026-06-30 |
| 21 | CAPSTONE INVESTMENT ADVISORS, LLC | $25.90M | 0.87% | 2026-06-30 |
| 22 | Squarepoint Ops LLC | $25.32M | 0.85% | 2026-06-30 |
| 23 | Cubist Systematic Strategies, LLC | $22.53M | 0.75% | 2025-09-30 |
| 24 | D. E. Shaw & Co., Inc. Custodian | $21.91M | 0.73% | 2026-06-30 |
| 25 | Qube Research & Technologies Ltd | $21.64M | 0.73% | 2026-06-30 |
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Jane Street Group, LLC Custodian | $481.16M | 21.01% | 2026-06-30 |
| 2 | Susquehanna International Group, LLP Custodian | $439.20M | 19.18% | 2026-06-30 |
| 3 | Citigroup Inc. Custodian | $226.02M | 9.87% | 2026-06-30 |
| 4 | UBS Group AG Custodian | $143.37M | 6.26% | 2026-06-30 |
| 5 | Millennium Management LLC Custodian | $116.42M | 5.08% | 2026-06-30 |
| 6 | Citadel Advisors LLC Custodian | $111.77M | 4.88% | 2026-06-30 |
| 7 | Goldman Sachs Group Inc Custodian | $106.34M | 4.64% | 2026-06-30 |
| 8 | IMC-Chicago, LLC Custodian | $80.21M | 3.50% | 2026-06-30 |
| 9 | CAPSTONE INVESTMENT ADVISORS, LLC | $65.67M | 2.87% | 2026-06-30 |
| 10 | Eisler Capital Management Ltd. | $52.99M | 2.31% | 2025-09-30 |
| 11 | Qube Research & Technologies Ltd | $45.14M | 1.97% | 2026-06-30 |
| 12 | Allianz Asset Management GmbH | $41.25M | 1.80% | 2026-06-30 |
| 13 | Hudson Bay Capital Management LP | $39.97M | 1.75% | 2026-06-30 |
| 14 | Simplex Trading, LLC Custodian | $39.67M | 1.73% | 2026-06-30 |
| 15 | Walleye Trading LLC | $37.16M | 1.62% | 2026-06-30 |
| 16 | BNP Paribas Financial Markets Custodian | $30.94M | 1.35% | 2026-06-30 |
| 17 | Point72 Asset Management, L.P. | $29.72M | 1.30% | 2026-06-30 |
| 18 | Wolverine Trading, LLC Custodian | $27.41M | 1.20% | 2025-09-30 |
| 19 | CREDIT AGRICOLE S A | $24.20M | 1.06% | 2026-06-30 |
| 20 | Balyasny Asset Management L.P. | $18.23M | 0.80% | 2026-06-30 |
| 21 | D. E. Shaw & Co., Inc. Custodian | $16.17M | 0.71% | 2026-06-30 |
| 22 | Walleye Capital LLC | $12.55M | 0.55% | 2026-06-30 |
| 23 | JPMorgan Chase & Co Custodian | $10.67M | 0.47% | 2026-06-30 |
| 24 | GROUP ONE TRADING LLC Custodian | $9.62M | 0.42% | 2026-06-30 |
| 25 | HSBC Holdings plc Custodian | $9.53M | 0.42% | 2026-06-30 |
PG Insider Trading (Form 4)
Latest: 2026-10-14| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-10-14 | Craig Arnold | Director | Award (A) | +1,438 | — | EDGAR | |
| 2026-10-14 | Amy Chang | Director | Award (A) | +1,438 | — | EDGAR | |
| 2026-10-14 | Rajesh Subramaniam | Director | Award (A) | +1,438 | — | EDGAR | |
| 2026-10-14 | Robert Jones Portman | Director | Award (A) | +1,438 | — | EDGAR | |
| 2026-10-14 | Christine M McCarthy | Director | Award (A) | +1,438 | — | EDGAR | |
| 2026-10-14 | Bertrand Marc Allen | Director | Award (A) | +1,438 | — | EDGAR | |
| 2026-10-14 | Christopher J Kempczinski | Director | Award (A) | +1,438 | — | EDGAR | |
| 2026-10-14 | Joseph Jimenez | Director | Award (A) | +1,438 | — | EDGAR | |
| 2026-10-14 | M. Brett Biggs | Director | Award (A) | +1,438 | — | EDGAR | |
| 2026-10-14 | Ashley McEvoy | Director | Award (A) | +1,438 | — | EDGAR | |
| 2026-10-14 | Sheila Bonini | Director | Award (A) | +1,438 | — | EDGAR | |
| 2026-10-06 | Paul Gama | CEO- Health Care | Sell (S) | −2,225 | $145.34 | -$323.4K | EDGAR |
| 2026-10-06 | Andre Schulten | Chief Financial Officer | Sell (S) | −3,914 | $145.34 | -$568.9K | EDGAR |
| 2026-10-06 | Susan Street Whaley | Chief Legal Officer & Secy | Sell (S) | −2,369 | $145.34 | -$344.3K | EDGAR |
| 2026-10-05 | Sundar G. Raman | CEO-Fabric Home & Habitat Care | Award (A) | — | — | EDGAR |
PG Insider Holdings
31 insiders · @ $161.02| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Jon R Moeller | Retired Chairman | 345,966 | $55.71M | -$336.21M | 118 | 2026-08-10 |
| 2 | Marc S. Pritchard | Chief Brand Officer | 187,107 | $30.13M | -$137.47M | 116 | 2026-10-05 |
| 3 | Jennifer L. Davis | CEO - Health Care | 77,303 | $12.45M | -$13.67M | 23 | 2025-12-05 |
| 4 | Shailesh Jejurikar | Chairman, President and CEO | 75,147 | $12.10M | -$72.80M | 65 | 2026-10-05 |
| 5 | Andre Schulten | Chief Financial Officer | 73,222 | $11.79M | -$22.51M | 39 | 2026-10-06 |
| 6 | Sundar G. Raman | CEO-Fabric Home & Habitat Care | 56,890 | $9.16M | -$16.05M | 31 | 2026-10-05 |
| 7 | Moses Victor Javier Aguilar | Chf Rsch, Dev & Innov Officer | 55,671 | $8.96M | -$9.38M | 40 | 2026-10-05 |
| 8 | Paul Gama | CEO- Health Care | 52,307 | $8.42M | -$811.7K | 5 | 2026-10-06 |
| 9 | Patricia A Woertz | Director | 51,548 | $8.30M | $100.0K | 42 | 2025-10-15 |
| 10 | Terry J Lundgren | Director | 43,958 | $7.08M | $0 | 63 | 2025-10-15 |
PG Board & Officers
As of SEC filings through Oct 14, 2026Directors 13
- Amy Chang · since Jun 1, 2017
- Joseph Jimenez · since Mar 1, 2018
- Christine M McCarthy · since Oct 8, 2019
- Debra L Lee · since Aug 12, 2020
- Bertrand Marc Allen · since Feb 10, 2021
- Christopher J Kempczinski · since Oct 12, 2021
- Rajesh Subramaniam · since Oct 11, 2022
- Robert Jones Portman · since Apr 11, 2023
- Sheila Bonini · since Apr 11, 2023
- M. Brett Biggs · since Oct 10, 2023
- Ashley McEvoy · since Dec 12, 2023
- Craig Arnold · since Jun 9, 2025
- Shailesh Jejurikar · listed since Dec 2025
Officers 12
- Freddy P. Bharucha · CEO - Beauty · since Dec 1, 2025
- Paul Gama · CEO- Health Care · since Apr 1, 2026
- El Hak Hesham Abd · CEO-Baby and Feminine Care · since Jun 1, 2026
- de Azevedo Juliana Monteiro Santos · CEO - Grooming · since Jul 1, 2026
- Shailesh Jejurikar · Chairman, President and CEO · listed since Aug 2026
- Sundar G. Raman · CEO-Fabric Home & Habitat Care · listed since Aug 2026
- Andre Schulten · Chief Financial Officer · since Mar 1, 2021
- Marc S. Pritchard · Chief Brand Officer · listed since Jan 2015
- Matthew W. Janzaruk · SVP - Chief Accounting Officer · since Mar 1, 2022
- Susan Street Whaley · Chief Legal Officer & Secy · since Jul 1, 2022
- Balaji Purushothaman · Chief Human Resources Officer · since Jan 1, 2023
- Moses Victor Javier Aguilar · Chf Rsch, Dev & Innov Officer · since Oct 1, 2020
Changes in the last 10 years (67)
| Aug 10, 2026 | Sundar G. Raman listed as CEO-Fabric Home & Habitat Care (previously CEO-Fabric & Home Care) in SEC filings |
| Aug 10, 2026 | Shailesh Jejurikar listed as Chairman, President and CEO (previously Chief Operating Officer) in SEC filings |
| Jul 29, 2026 | The company announced the departure of Jon R Moeller from the board in an SEC filing |
| Jul 29, 2026 | The company announced the departure of Jon R Moeller as Chairman, President and CEO in an SEC filing |
| Jul 1, 2026 | de Azevedo Juliana Monteiro Santos became CEO - Grooming |
| Jun 1, 2026 | El Hak Hesham Abd became CEO-Baby and Feminine Care |
| Apr 1, 2026 | Paul Gama became CEO- Health Care |
| Dec 9, 2025 | The company announced the departure of Jennifer L. Davis as CEO - Health Care in an SEC filing |
| Dec 5, 2025 | Shailesh Jejurikar first listed as a director in an SEC filing |
| Dec 1, 2025 | Freddy P. Bharucha became CEO - Beauty |
| Oct 15, 2025 | Terry J Lundgren reported in an SEC filing no longer being a director |
| Oct 15, 2025 | Patricia A Woertz reported in an SEC filing no longer being a director |
| Aug 12, 2025 | The company announced the departure of R. Alexandra Keith as CEO - Beauty in an SEC filing |
| Jun 9, 2025 | Craig Arnold became a director |
| Jun 12, 2024 | Angela F Braly reported in an SEC filing no longer being a director |
| Dec 12, 2023 | Ashley McEvoy became a director |
| Oct 10, 2023 | M. Brett Biggs became a director |
| Apr 11, 2023 | Sheila Bonini became a director |
| Apr 11, 2023 | Robert Jones Portman became a director |
| Jan 1, 2023 | Balaji Purushothaman became Chief Human Resources Officer |
| Oct 11, 2022 | Rajesh Subramaniam became a director |
| Aug 4, 2022 | Jon R Moeller listed as Chairman, President and CEO (previously President and CEO) in SEC filings |
| Jul 1, 2022 | Susan Street Whaley became Chief Legal Officer & Secy |
| Apr 14, 2022 | The company announced the departure of David S Taylor as Executive Chairman in an SEC filing |
| Apr 1, 2022 | Jennifer L. Davis became CEO - Health Care |
| Mar 1, 2022 | Matthew W. Janzaruk became SVP - Chief Accounting Officer |
| Jan 7, 2022 | The company announced the departure of Michael G. Homan as SVP - Chief Accounting Officer in an SEC filing |
| Dec 10, 2021 | The company announced the departure of Margaret C Whitman from the board in an SEC filing |
| Dec 7, 2021 | Jon R Moeller listed as President and CEO (previously Vice Chairman and COO) in SEC filings |
| Dec 7, 2021 | Jon R Moeller first listed as a director in an SEC filing |
| Nov 12, 2021 | David S Taylor listed as Executive Chairman (previously Chairman, President & CEO) in SEC filings |
| Oct 12, 2021 | Christopher J Kempczinski became a director |
| Oct 5, 2021 | Shailesh Jejurikar listed as Chief Operating Officer (previously CEO - Fabric & Home Care) in SEC filings |
| Oct 5, 2021 | Ma. Fatima Francisco listed as CEO - Baby, Fem & Family Care (previously CEO - Baby & Feminine Care) in SEC filings |
| Oct 1, 2021 | Sundar G. Raman became CEO-Fabric & Home Care |
| Aug 2, 2021 | Carolyn M Tastad listed as CEO - Health Care (previously Group Pres-Chief Sales Officer) in SEC filings |
| May 5, 2021 | Jon R Moeller listed as Vice Chairman and COO (previously Vice Chairman, COO and CFO) in SEC filings |
| Mar 1, 2021 | Michael G. Homan became SVP - Chief Accounting Officer |
| Mar 1, 2021 | Andre Schulten became Chief Financial Officer |
| Feb 10, 2021 | Bertrand Marc Allen became a director |
| Oct 1, 2020 | Moses Victor Javier Aguilar became Chf Rsch, Dev & Innov Officer |
| Aug 12, 2020 | Debra L Lee became a director |
| Aug 3, 2020 | Valarie L Sheppard listed as Controller, Treas. & Group VP (previously Controller, Treas. & Exec. VP) in SEC filings |
| Nov 20, 2019 | Jon R Moeller listed as Vice Chairman, COO and CFO (previously Vice Chairman and CFO) in SEC filings |
| Oct 8, 2019 | Christine M McCarthy became a director |
| Aug 22, 2019 | Carolyn M Tastad listed as Group Pres-Chief Sales Officer (previously Group President - NA SMO) in SEC filings |
| Aug 2, 2019 | Steven D Bishop listed as CEO - Health Care (previously Group President Global Health) in SEC filings |
| Aug 2, 2019 | Shailesh Jejurikar listed as CEO - Fabric & Home Care (previously President - Global Fabric Care) in SEC filings |
| Aug 2, 2019 | R. Alexandra Keith listed as CEO - Beauty (previously President Global Hair & Beauty) in SEC filings |
| Aug 2, 2019 | MaryLynn FergusonMchugh listed as CEO - Family Care & P&G Ventur (previously Group President Global Family) in SEC filings |
| Aug 2, 2019 | Ma. Fatima Francisco listed as CEO - Baby & Feminine Care (previously President - Global Baby) in SEC filings |
| Aug 2, 2019 | Gary A Coombe listed as CEO - Grooming (previously President-Global Grooming) in SEC filings |
| May 1, 2019 | Valarie L Sheppard listed as Controller, Treas. & Exec. VP (previously Sr VP, Comptroller & Treasurer) in SEC filings |
| Aug 1, 2018 | Shailesh Jejurikar became President - Global Fabric Care |
| Aug 1, 2018 | Mary Theresa Grabowski became Chief Human Resources Officer |
| Aug 1, 2018 | Ma. Fatima Francisco became President - Global Baby |
| Jul 2, 2018 | David S Taylor listed as Chairman, President & CEO (previously President & CEO) in SEC filings |
| Mar 2, 2018 | Gary A Coombe listed as President-Global Grooming (previously President-Europe SMO) in SEC filings |
| Mar 1, 2018 | Trian Fund Management, L.p. became a director |
| Mar 1, 2018 | Nelson Peltz became a director |
| Mar 1, 2018 | Loic Tassel became President - Europe SMO |
| Mar 1, 2018 | Joseph Jimenez became a director |
| Feb 1, 2018 | Kathleen B Fish listed as Chf Rsch, Dev & Innv Officer (previously Chief Technology Officer) in SEC filings |
| Aug 17, 2017 | Jon R Moeller listed as Vice Chairman and CFO (previously Chief Financial Officer) in SEC filings |
| Jul 1, 2017 | R. Alexandra Keith became President Global Hair & Beauty |
| Jun 1, 2017 | Amy Chang became a director |
| May 26, 2017 | Patrice Louvet reported in an SEC filing no longer being Group President, Global Beauty |
- Prev
- 1
Not reported recently (27)
- Ma. Fatima Francisco · Last reported as CEO - Baby, Fem & Family Care in an SEC filing dated Mar 2, 2026
- Gary A Coombe · Last reported as CEO - Grooming in an SEC filing dated Feb 13, 2026
- Mary Theresa Grabowski · Last reported as Chief Human Resources Officer in an SEC filing dated Dec 9, 2022
- David S Taylor · Last reported as a director in an SEC filing dated Apr 26, 2022
- Deborah P Majoras · Last reported as Chief Legal Officer & Secy in an SEC filing dated Mar 3, 2022
- Carolyn M Tastad · Last reported as CEO - Health Care in an SEC filing dated Mar 3, 2022
- W James McNerney Jr · Last reported as a director in an SEC filing dated Sep 15, 2021
- Francis S Blake · Last reported as a director in an SEC filing dated Sep 15, 2021
- Nelson Peltz · Last reported as a director in an SEC filing dated Sep 2, 2021
- Trian Fund Management, L.p. · Last reported as a director in an SEC filing dated Sep 2, 2021
- MaryLynn FergusonMchugh · Last reported as CEO - Family Care & P&G Ventur in an SEC filing dated Aug 19, 2021
- Steven D Bishop · Last reported as CEO - Health Care in an SEC filing dated May 13, 2021
- Valarie L Sheppard · Last reported as Controller, Treas. & Group VP in an SEC filing dated Feb 26, 2021
- Kathleen B Fish · Last reported as Chf Rsch, Dev & Innv Officer in an SEC filing dated Dec 17, 2020
- Scott D Cook · Last reported as a director in an SEC filing dated Dec 12, 2019
- Jeffrey K Schomburger · Last reported as Global Sales Officer, CBD in an SEC filing dated May 17, 2019
- Ioannis Skoufalos · Last reported as Global Product Supply Officer in an SEC filing dated May 15, 2019
- Suranjan Magesvaran · Last reported as President - Asia Pacific SMO in an SEC filing dated May 15, 2019
- Juan Fernando Posada · Last reported as President - LA SMO in an SEC filing dated May 6, 2019
- Loic Tassel · Last reported as President - Europe SMO in an SEC filing dated May 3, 2019
- Price Matthew · Last reported as President - Greater China SMO in an SEC filing dated May 2, 2019
- Kenneth I Chenault · Last reported as a director in an SEC filing dated Dec 12, 2018
- Ernesto Zedillo · Last reported as a director in an SEC filing dated Oct 11, 2018
- Ciserani Giovanni · Last reported as GrpPres-Global F&HC,Baby&Fem in an SEC filing dated Jul 2, 2018
- Mark F Biegger · Last reported as Chief Human Resources Officer in an SEC filing dated Mar 2, 2018
- Charles E Pierce · Last reported as Group President Global Groomin in an SEC filing dated Mar 2, 2018
- Mohamed Samir Abdelrazek Abdelfattah · Last reported as President - IMEA SMO in an SEC filing dated Aug 17, 2017
PG Proposed Insider Sales (Form 144)
Latest: 2026-10-22What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-10-22 | Gama Paul | Officer | 14,623 | $2.31M | 2026-10-23 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2026-10-22 | Jejurikar Shailesh | Officer, Director | 35,000 | $5.52M | 2026-10-23 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2026-10-22 | Purushothaman Balaji | Officer | 4,181 | $659.5K | 2026-10-23 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2026-10-22 | Raman Sundar G. | Officer | 38,253 | $6.03M | 2026-10-23 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2026-10-01 | Moeller Jon R | Officer, Director | 8,087 | $1.20M | 2026-10-02 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2026-10-01 | Whaley Susan Street | Officer | 2,817 | $416.5K | 2026-10-02 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2026-10-01 | Schulten Andre | Officer | 4,655 | $688.2K | 2026-10-02 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2026-10-01 | Gama Paul | Officer | 2,646 | $391.2K | 2026-10-02 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2026-08-24 | Gama Paul | Officer | 4,331 | $622.4K | 2026-08-25 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2026-08-21 | Janzaruk Matthew W. | Officer | 359 | $51.6K | 2026-08-24 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| Filing Date | Accession | Link |
|---|---|---|
| 2026-04-24 | 0000080424-26-000056 | EDGAR |
| 2026-04-24 | 0000080424-26-000057 | EDGAR |
| 2026-04-14 | 0000080424-26-000048 | EDGAR |
| 2026-01-22 | 0000080424-26-000006 | EDGAR |
| 2026-01-22 | 0000080424-26-000009 | EDGAR |
| 2026-01-13 | 0000080424-26-000002 | EDGAR |
| 2025-12-15 | 0000080424-25-000287 | EDGAR |
| 2025-11-04 | 0001193125-25-264728 | EDGAR |
| 2025-11-03 | 0001193125-25-262609 | EDGAR |
| 2025-10-24 | 0000080424-25-000240 | EDGAR |
| Filing Date | Accession | Link |
|---|---|---|
| 2026-04-24 | 0000080424-26-000060 | EDGAR |
| 2026-01-23 | 0000080424-26-000011 | EDGAR |
| 2025-10-24 | 0000080424-25-000245 | EDGAR |
| 2025-04-24 | 0000080424-25-000037 | EDGAR |
| 2025-01-22 | 0000080424-25-000013 | EDGAR |
| 2024-10-18 | 0000080424-24-000113 | EDGAR |
| 2024-04-19 | 0000080424-24-000051 | EDGAR |
| 2024-01-23 | 0000080424-24-000018 | EDGAR |
| 2023-10-18 | 0000080424-23-000103 | EDGAR |
| 2023-04-21 | 0000080424-23-000046 | EDGAR |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.46% | $10.7B | — | 2026-09-30 |
| 2 | VOO Vanguard S&P 500 ETF | Vanguard | 0.51% | $8.9B | — | 2026-09-30 |
| 3 | IVV iShares Core S&P 500 ETF | iShares (BlackRock) | 0.58% | $5.1B | $873.6B | 2026-10-22 |
| 4 | SPY State Street® SPDR® S&P 500® ETF Trust | SPDR (State Street) | 0.58% | $4.7B | $810.5B | 2026-10-22 |
| 5 | SCHD Schwab U.S. Dividend Equity ETF | Nport | 3.55% | $3.4B | — | 2026-05-31 |
| 6 | VTV Vanguard Morningstar Value ETF | Vanguard | 1.28% | $3.2B | — | 2026-09-30 |
| 7 | VIG Vanguard Dividend Appreciation ETF | Vanguard | 1.50% | $1.9B | — | 2026-09-30 |
| 8 | VYM Vanguard High Dividend Yield ETF | Vanguard | 1.44% | $1.4B | — | 2026-09-30 |
| 9 | XLP State Street® Consumer Staples Select Sector SPDR® ETF | SPDR (State Street) | 7.69% | $1.2B | $15.1B | 2026-10-22 |
| 10 | DGRO iShares Core Dividend Growth ETF | iShares (BlackRock) | 2.50% | $1.1B | $44.5B | 2026-10-22 |
| 11 | SPYM State Street® SPDR® Portfolio S&P 500® ETF | SPDR (State Street) | 0.58% | $1.1B | $182.5B | 2026-10-22 |
| 12 | HDV iShares Core High Dividend ETF | iShares (BlackRock) | 5.63% | $903.3M | $16.0B | 2026-10-22 |
| 13 | IWD iShares Russell 1000 Value ETF | iShares (BlackRock) | 1.02% | $866.0M | $84.5B | 2026-10-22 |
| 14 | VDC Vanguard Consumer Staples ETF | Vanguard | 9.93% | $862.2M | — | 2026-09-30 |
| 15 | DIA State Street® SPDR® Dow Jones Industrial Average® ETF Trust | SPDR (State Street) | 1.85% | $845.6M | $45.7B | 2026-10-22 |
| 16 | IVE iShares S&P 500 Value ETF | iShares (BlackRock) | 1.26% | $639.6M | $50.4B | 2026-10-22 |
| 17 | SPHQ Invesco S&P 500 Quality ETF | Invesco | 3.29% | $605.2M | — | 2026-10-24 |
| 18 | ITOT iShares Core S&P Total U.S. Stock Market ETF | iShares (BlackRock) | 0.52% | $500.4M | $95.8B | 2026-10-22 |
| 19 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.56% | $490.5M | — | 2026-10-22 |
| 20 | SPYV State Street® SPDR® Portfolio S&P 500® Value ETF | SPDR (State Street) | 1.25% | $486.3M | $38.8B | 2026-10-22 |
| 21 | QUAL iShares MSCI USA Quality Factor ETF | iShares (BlackRock) | 0.92% | $446.9M | $48.2B | 2026-10-22 |
| 22 | VV Vanguard Morningstar Large-Cap ETF | Vanguard | 0.52% | $397.8M | — | 2026-09-30 |
| 23 | SCHX Schwab U.S. Large-Cap ETF | Nport | 0.49% | $354.5M | — | 2026-05-31 |
| 24 | IUSV iShares Core S&P U.S. Value ETF | iShares (BlackRock) | 1.20% | $340.0M | $28.3B | 2026-10-22 |
| 25 | SDY State Street® SPDR® S&P® Dividend ETF | SPDR (State Street) | 1.37% | $304.2M | $22.2B | 2026-10-22 |
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q1 '27 | 2026-09-30 | $23.28B | $4.66B | $1.97 | $5.77B |
| Q4 '26 | 2026-06-30 | $21.20B | $2.97B | $1.26 | $5.13B |
| Q3 '26 | 2026-03-31 | $21.23B | $3.86B | $1.63 | $4.04B |
| Q2 '26 | 2025-12-31 | $22.21B | $4.25B | $1.78 | $4.97B |
| Q1 '26 | 2025-09-30 | $22.39B | $4.68B | $1.95 | $5.41B |
| Q4 '25 | 2025-06-30 | $20.89B | $3.54B | $1.48 | $4.99B |
| Q3 '25 | 2025-03-31 | $19.78B | $3.70B | $1.54 | $3.71B |
| Q2 '25 | 2024-12-31 | $21.88B | $4.56B | $1.88 | $4.83B |
| Q1 '25 | 2024-09-30 | $21.74B | $3.89B | $1.61 | $4.30B |
| Q4 '24 | 2024-06-30 | $20.53B | $3.06B | $1.27 | $5.75B |
| Q3 '24 | 2024-03-31 | $20.20B | $3.69B | $1.52 | $4.09B |
| Q2 '24 | 2023-12-31 | $21.44B | $3.40B | $1.40 | $5.10B |
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.